Insider Trading activities at Haemonetics Corp (HAE) , Part 2

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp (HAE) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Haemonetics Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 313143.

Total stock buying since 2014: $2,423,480.
Total stock sales since 2014: $117,261,539.
Total stock option exercises since 2014: $45,452,203.


 1   2 
30 insiders reported insider trading activities at Haemonetics Corp (HAE):
Insider trading activities of Dockendorff Charles J
Insider trading activities of Foote Susan Bartlett
Insider trading activities of Mcdaniel Kathleen
Insider trading activities of Kroll Mark W
Insider trading activities of Gelbman Ronald G
Insider trading activities of Davies Kent J
Insider trading activities of Basil Michelle L
Insider trading activities of Allen Peter M
Insider trading activities of Lindop Christopher J
Insider trading activities of Concannon Brian
Insider trading activities of Goldstein Dan
Insider trading activities of Bolorforosh Said
Insider trading activities of Miller Laurie A.
Insider trading activities of Simon, Christopher
Insider trading activities of Lingamneni Anila
Insider trading activities of Llorens Josep
Insider trading activities of White Jonathan
Insider trading activities of Abernathy Robert E
Insider trading activities of Merriman Ronald
Insider trading activities of Burke William P. Mr.
Insider trading activities of Scanlan Jacqueline
Insider trading activities of Granadillo Pedro P
Insider trading activities of Selman Byron
Insider trading activities of Ryding Neil Mr.
Insider trading activities of Hanlon Susan M
Insider trading activities of Strong Stewart W
Insider trading activities of Best Lawrence C
Insider trading activities of Jesse Sandra
Insider trading activities of Burns Brian R
Insider trading activities of Meelia Richard J

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Haemonetics Corp (HAE).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2024 0 $0 38,339 $3,463,122 109,167 $4,617,635
2023 0 $0 22,518 $1,982,726 208,567 $6,304,686
2022 0 $0 347,292 $26,657,770 265,710 $12,102,291
2021 0 $0 73,005 $6,256,396 57,986 $2,210,283
2020 4,000 $323,720 144,116 $13,112,950 14,474 $604,744
2019 0 $0 292,546 $33,522,423 71,638 $2,947,916
2018 0 $0 115,174 $12,058,890 74,939 $2,804,531
2017 0 $0 143,148 $6,548,301 136,879 $4,682,353
2016 60,000 $2,099,760 25,056 $912,447 20,338 $583,166
2015 0 $0 208,434 $8,620,345 205,637 $5,689,540
2014 0 $0 118,607 $4,126,169 115,927 $2,905,058


Table 3. Detailed insider trading at Haemonetics Corp (HAE) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-10-01 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 7,164 126.67 907,478
2019-10-01 Burke William P. Mr. (EVP, Chief Financial Officer) Option Ex 5,718 41.64 238,097
2019-09-09 Scanlan Jacqueline (SVP, Global Human Resources) Sale 1,531 127.44 195,110
2019-09-09 Scanlan Jacqueline (SVP, Global Human Resources) Option Ex 1,308 93.52 122,324
2019-09-05 Llorens Josep (SVP, Global Manufacturing) Sale 101 129.94 13,123
2019-08-30 Bolorforosh Said (EVP, Chief Technology Officer) Sale 657 133.73 87,860
2019-08-30 Bolorforosh Said (EVP, Chief Technology Officer) Option Ex 832 93.52 77,808
2019-08-19 Simon, Christopher (President & CEO) Sale 50,869 137.43 6,990,926
2019-08-09 Goldstein Dan (VP, Corporate Controller) Sale 475 133.23 63,284
2019-08-09 Goldstein Dan (VP, Corporate Controller) Option Ex 475 93.52 44,422
2019-08-08 Gelbman Ronald G (Director) Sale 1,696 134.15 227,518
2019-07-01 Simon, Christopher (President & CEO) Sale 5,008 121.79 609,924
2019-06-17 Scanlan Jacqueline (SVP, Global Human Resources) Sale 3,646 112.49 410,138
2019-06-17 Scanlan Jacqueline (SVP, Global Human Resources) Option Ex 2,890 41.64 120,339
2019-06-13 Goldstein Dan (VP, Corporate Controller) Sale 94 110.58 10,394
2019-06-12 Bolorforosh Said (EVP, Chief Technology Officer) Sale 69 109.37 7,546
2019-06-12 Goldstein Dan (VP, Corporate Controller) Sale 39 109.37 4,265
2019-06-12 Scanlan Jacqueline (SVP, Global Human Resources) Sale 108 109.37 11,811
2019-06-12 Basil Michelle L (EVP and General Counsel) Sale 231 109.37 25,264
2019-06-12 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 190 109.37 20,780
2019-06-12 Simon, Christopher (President & CEO) Sale 1,248 109.37 136,493
2019-06-10 Goldstein Dan (VP, Corporate Controller) Sale 192 104.38 20,040
2019-06-07 Goldstein Dan (VP, Corporate Controller) Sale 78 103.38 8,063
2019-06-07 Scanlan Jacqueline (SVP, Global Human Resources) Sale 208 103.38 21,503
2019-06-07 Basil Michelle L (EVP and General Counsel) Sale 7,187 103.44 743,423
2019-06-07 Basil Michelle L (EVP and General Counsel) Option Ex 4,872 38.43 187,230
2019-06-07 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 411 103.38 42,489
2019-06-07 Simon, Christopher (President & CEO) Sale 2,834 103.38 292,978
2019-06-06 Goldstein Dan (VP, Corporate Controller) Sale 1,107 103.25 114,297
2019-06-06 Goldstein Dan (VP, Corporate Controller) Option Ex 1,107 41.64 46,095
2019-06-06 Basil Michelle L (EVP and General Counsel) Sale 6,148 103.25 634,781
2019-06-06 Basil Michelle L (EVP and General Counsel) Option Ex 6,148 41.64 256,002
2019-05-23 Simon, Christopher (President & CEO) Sale 24,412 99.39 2,426,308
2019-05-14 Scanlan Jacqueline (SVP, Global Human Resources) Sale 1,508 100.00 150,800
2019-05-14 Scanlan Jacqueline (SVP, Global Human Resources) Option Ex 1,299 38.43 49,920
2019-05-13 Simon, Christopher (President & CEO) Sale 57,587 94.51 5,442,547
2019-04-09 Goldstein Dan (VP, Corporate Controller) Sale 389 88.99 34,617
2019-04-08 Goldstein Dan (VP, Corporate Controller) Sale 2,817 88.62 249,642
2019-04-08 Goldstein Dan (VP, Corporate Controller) Option Ex 2,607 34.42 89,732
2019-03-07 Scanlan Jacqueline (SVP, Global Human Resources) Sale 116 83.57 9,694
2019-03-07 Basil Michelle L (EVP and General Counsel) Sale 391 83.57 32,675
2019-02-15 Gelbman Ronald G (Director) Sale 8,196 86.52 709,117
2019-02-15 Gelbman Ronald G (Director) Option Ex 8,196 36.37 298,088
2018-12-14 Meelia Richard J (Director) Sale 8,196 102.86 843,040
2018-12-14 Meelia Richard J (Director) Option Ex 8,196 36.37 298,088
2018-12-14 Gelbman Ronald G (Director) Sale 4,329 103.02 445,973
2018-12-12 Scanlan Jacqueline (SVP, Global Human Resources) Sale 1,027 104.22 107,033
2018-12-10 Goldstein Dan (VP, Corporate Controller) Sale 1,693 102.91 174,226
2018-12-10 Goldstein Dan (VP, Corporate Controller) Option Ex 1,457 34.21 49,843
2018-11-08 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 13,056 114.33 1,492,692
2018-11-08 Burke William P. Mr. (EVP, Chief Financial Officer) Option Ex 11,232 34.21 384,246
2018-11-08 Granadillo Pedro P (Director) Sale 12,322 114.50 1,410,869
2018-11-07 Kroll Mark W (Director) Sale 10,707 114.00 1,220,598
2018-11-07 Kroll Mark W (Director) Option Ex 8,196 36.37 298,088
2018-10-26 Goldstein Dan (VP, Corporate Controller) Sale 102 101.69 10,372
2018-10-26 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 779 101.69 79,216
2018-09-17 Granadillo Pedro P (Director) Sale 30,824 111.54 3,437,985
2018-09-17 Granadillo Pedro P (Director) Option Ex 25,122 39.11 982,446
2018-09-10 Scanlan Jacqueline (SVP, Global Human Resources) Sale 4,890 112.19 548,609
2018-09-10 Scanlan Jacqueline (SVP, Global Human Resources) Option Ex 4,188 40.03 167,666
2018-07-02 Simon, Christopher (President & CEO) Sale 5,139 89.31 458,964
2018-06-25 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 6,687 92.17 616,340
2018-06-25 Burke William P. Mr. (EVP, Chief Financial Officer) Option Ex 5,717 41.64 238,055
2018-06-08 Goldstein Dan (VP, Corporate Controller) Sale 578 92.90 53,696
2018-06-07 Goldstein Dan (VP, Corporate Controller) Sale 81 92.73 7,511
2018-06-07 Scanlan Jacqueline (SVP, Global Human Resources) Sale 214 92.73 19,844
2018-06-07 Basil Michelle L (EVP and General Counsel) Sale 457 92.73 42,377
2018-06-07 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 425 92.73 39,410
2018-06-07 Simon, Christopher (President & CEO) Sale 1,941 92.73 179,988
2018-06-07 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 183 92.73 16,969
2018-06-06 Goldstein Dan (VP, Corporate Controller) Sale 3,713 95.14 353,254
2018-06-06 Goldstein Dan (VP, Corporate Controller) Option Ex 3,713 38.03 141,205
2018-04-06 Goldstein Dan (VP, Corporate Controller) Sale 210 72.19 15,159
2018-03-06 Scanlan Jacqueline (SVP, Global Human Resources) Sale 114 72.23 8,234
2018-03-06 Basil Michelle L (EVP and General Counsel) Sale 389 72.23 28,097
2018-01-02 Kroll Mark W (Director) Sale 7,118 63.00 448,434
2018-01-02 Kroll Mark W (Director) Option Ex 7,118 34.41 244,894
2017-12-01 Granadillo Pedro P (Director) Sale 7,118 57.09 406,331
2017-12-01 Granadillo Pedro P (Director) Option Ex 7,118 34.41 244,894
2017-11-16 Gelbman Ronald G (Director) Sale 5,440 56.68 308,350
2017-11-16 Gelbman Ronald G (Director) Option Ex 7,118 34.41 244,894
2017-11-14 Burke Willaim P (EVP, Chief Financial Officer) Sale 13,193 54.19 714,862
2017-11-14 Burke Willaim P (EVP, Chief Financial Officer) Option Ex 11,231 34.21 384,212
2017-11-13 Goldstein Dan (Chief Accounting Officer) Sale 4,691 54.91 257,606
2017-11-13 Goldstein Dan (Chief Accounting Officer) Option Ex 4,063 34.31 139,421
2017-11-10 Foote Susan Bartlett (Director) Sale 16,926 54.22 917,727
2017-11-10 Foote Susan Bartlett (Director) Option Ex 16,926 40.48 685,096
2017-10-25 Goldstein Dan (VP, Corporate Controller) Sale 111 46.76 5,190
2017-10-25 Burke William P. Mr. (EVP, Chief Financial Officer) Sale 841 46.76 39,325
2017-10-25 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 267 46.76 12,484
2017-10-20 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 346 45.70 15,812
2017-08-10 Meelia Richard J (Director) Sale 24,086 42.06 1,013,105
2017-08-10 Meelia Richard J (Director) Option Ex 24,086 33.68 811,288
2017-07-19 Goldstein Dan (VP, Corporate Controller) Sale 197 40.39 7,956
2017-06-29 Simon, Christopher (President & CEO) Sale 3,595 40.39 145,202
2017-05-22 Merriman Ronald (Director) Sale 25,667 40.32 1,034,912
2017-05-22 Merriman Ronald (Director) Option Ex 25,667 34.41 865,091
2017-05-15 Kroll Mark W (Director) Sale 8,580 41.49 355,992
2017-05-15 Kroll Mark W (Director) Option Ex 8,580 27.24 233,719
2017-05-11 Foote Susan Bartlett (Director) Sale 15,314 41.78 639,818
2017-05-11 Foote Susan Bartlett (Director) Option Ex 15,314 35.39 541,931
2017-03-24 Gelbman Ronald G (Director) Sale 8,580 40.00 343,200
2017-03-24 Gelbman Ronald G (Director) Option Ex 8,580 27.24 233,719
2016-12-12 Gelbman Ronald G (Director) Sale 5,683 40.30 229,024
2016-10-20 Ryding Neil Mr. (EVP, Global Manufacturing) Sale 351 34.16 11,990
2016-08-17 Merriman Ronald (Director) Sale 4,337 35.15 152,436
2016-08-05 Foote Susan Bartlett (Director) Sale 14,685 35.34 518,997
2016-08-05 Foote Susan Bartlett (Director) Option Ex 8,580 27.24 233,719
2016-08-04 Simon, Christopher (President & CEO) Buy 60,000 35.00 2,099,760
2016-07-29 Gelbman Ronald G (Director) Option Ex 11,758 29.72 349,447
2015-10-26 Selman Byron (President, Global Markets) Sale 344 32.13 11,052
2015-10-26 Jesse Sandra (EVP and Chief Legal Officer) Sale 778 32.13 24,996
2015-10-26 White Jonathan (Chief Science and Technology) Sale 319 32.13 10,249
2015-10-26 Lindop Christopher J (CFO & EVP Business Development) Sale 436 32.13 14,008
2015-10-26 Hanlon Susan M (VP Finance) Sale 497 32.13 15,968
2015-10-23 Selman Byron (President, Global Markets) Sale 191 31.75 6,064
2015-10-23 Jesse Sandra (EVP and Chief Legal Officer) Sale 250 31.75 7,937
2015-10-23 White Jonathan (Chief Science and Technology) Sale 250 31.75 7,937
2015-10-23 Davies Kent J (Chief Operating Officer) Sale 278 31.75 8,826
2015-10-23 Burns Brian R (EVP, Global QA/RA) Sale 249 31.75 7,905
2015-10-23 Hanlon Susan M (VP Finance) Sale 162 31.75 5,143
2015-09-15 Concannon Brian (President & CEO) Sale 6,569 35.15 230,900
2015-09-15 Concannon Brian (President & CEO) Option Ex 6,569 27.69 181,895
2015-09-01 Concannon Brian (President & CEO) Sale 4,765 35.63 169,791
2015-09-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-08-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 38.49 188,687
2015-08-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-08-17 Concannon Brian (President & CEO) Sale 6,569 39.28 258,017
2015-08-17 Concannon Brian (President & CEO) Option Ex 6,569 27.68 181,862
2015-08-03 Concannon Brian (President & CEO) Sale 4,765 39.91 190,190
2015-08-03 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-07-23 Davies Kent J (President, Global Markets) Sale 279 39.36 10,981
2015-07-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 39.09 191,609
2015-07-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-07-15 Concannon Brian (President & CEO) Sale 6,569 39.59 260,092
2015-07-15 Concannon Brian (President & CEO) Option Ex 6,569 27.68 181,862
2015-07-06 Allen Peter M (President, Global Plasma) Sale 30,494 40.19 1,225,645
2015-07-06 Allen Peter M (President, Global Plasma) Option Ex 30,494 27.27 831,723
2015-07-02 White Jonathan (Chief Science and Technology) Sale 2,385 41.14 98,118
2015-07-01 Concannon Brian (President & CEO) Sale 4,765 41.28 196,713
2015-07-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-06-22 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 42.51 208,393
2015-06-22 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-06-15 Concannon Brian (President & CEO) Sale 6,569 42.51 279,221
2015-06-15 Concannon Brian (President & CEO) Option Ex 6,569 27.68 181,862
2015-06-10 Hanlon Susan M (VP Finance) Sale 6,000 43.00 258,000
2015-06-10 Hanlon Susan M (VP Finance) Option Ex 6,000 27.50 164,970
2015-06-01 Concannon Brian (President & CEO) Sale 4,765 41.39 197,213
2015-06-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-05-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 41.65 204,173
2015-05-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-05-05 Hanlon Susan M (VP Finance) Sale 4,000 40.08 160,300
2015-05-05 Hanlon Susan M (VP Finance) Option Ex 4,000 26.47 105,880
2015-05-01 Concannon Brian (President & CEO) Sale 4,765 40.74 194,140
2015-05-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-04-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 41.55 203,678
2015-04-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-04-01 Concannon Brian (President & CEO) Sale 4,765 44.51 212,075
2015-04-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-03-27 Hanlon Susan M (VP Finance) Sale 7,000 43.47 304,255
2015-03-27 Hanlon Susan M (VP Finance) Option Ex 7,000 26.47 185,290
2015-03-20 Lindop Christopher J (CFO & EVP Business Development) Sale 4,902 44.26 216,982
2015-03-20 Lindop Christopher J (CFO & EVP Business Development) Option Ex 4,902 26.32 128,996
2015-03-10 Foote Susan Bartlett (Director) Sale 11,328 43.84 496,642
2015-03-10 Foote Susan Bartlett (Director) Option Ex 11,328 29.23 331,117
2015-03-05 Gelbman Ronald G (Director) Sale 7,707 44.76 344,934
2015-03-05 Gelbman Ronald G (Director) Option Ex 11,328 29.23 331,117
2015-03-04 Merriman Ronald (Director) Sale 14,258 43.80 624,471
2015-03-04 Merriman Ronald (Director) Option Ex 14,258 28.48 406,067
2015-03-02 Concannon Brian (President & CEO) Sale 4,765 44.41 211,618
2015-03-02 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-02-27 Kroll Mark W (Director) Sale 11,328 44.80 507,483
2015-02-27 Kroll Mark W (Director) Option Ex 11,328 29.23 331,117
2015-02-18 Granadillo Pedro P (Director) Sale 11,328 43.45 492,156
2015-02-18 Granadillo Pedro P (Director) Option Ex 11,328 29.23 331,117
2015-02-02 Concannon Brian (President & CEO) Sale 4,765 39.15 186,530
2015-02-02 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2015-01-02 Concannon Brian (President & CEO) Sale 4,765 37.20 177,253
2015-01-02 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2014-12-01 Concannon Brian (President & CEO) Sale 4,765 36.72 174,980
2014-12-01 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2014-11-03 Concannon Brian (President & CEO) Sale 4,765 35.86 170,887
2014-11-03 Concannon Brian (President & CEO) Option Ex 4,765 27.27 129,965
2014-10-13 Allen Peter M (President, Global Plasma) Sale 36,426 35.22 1,282,814
2014-10-13 Allen Peter M (President, Global Plasma) Option Ex 36,426 25.54 930,137
2014-08-28 Mcdaniel Kathleen (EVP Global Human Resources) Sale 406 35.46 14,396
2014-08-12 Merriman Ronald (Director) Sale 13,602 35.81 487,114
2014-08-12 Merriman Ronald (Director) Option Ex 11,328 29.23 331,117
2014-08-01 Concannon Brian (President & CEO) Sale 4,380 35.27 154,465
2014-08-01 Concannon Brian (President & CEO) Option Ex 4,380 25.54 111,843
2014-07-07 Granadillo Pedro P (Director) Sale 5,837 35.95 209,863
2014-07-07 Granadillo Pedro P (Director) Option Ex 5,837 19.95 116,471
2014-07-01 Concannon Brian (President & CEO) Sale 4,600 35.83 164,799
2014-07-01 Concannon Brian (President & CEO) Option Ex 4,600 25.54 117,461
2014-06-12 Gelbman Ronald G (Director) Sale 9,184 34.00 312,283
2014-06-12 Gelbman Ronald G (Director) Option Ex 9,184 24.96 229,232
2014-06-12 Best Lawrence C (Director) Sale 9,184 33.91 311,438
2014-06-12 Best Lawrence C (Director) Option Ex 9,184 24.96 229,232
2014-06-06 Granadillo Pedro P (Director) Sale 5,837 34.69 202,503
2014-06-06 Granadillo Pedro P (Director) Option Ex 5,837 19.95 116,471
2014-06-02 Concannon Brian (President & CEO) Sale 4,600 33.54 154,302
2014-06-02 Concannon Brian (President & CEO) Option Ex 4,600 25.54 117,461
2014-05-12 Foote Susan Bartlett (Director) Sale 9,184 33.16 304,550
2014-05-12 Foote Susan Bartlett (Director) Option Ex 9,184 24.96 229,232
2014-05-07 Granadillo Pedro P (Director) Sale 5,837 31.14 181,775
2014-05-07 Granadillo Pedro P (Director) Option Ex 5,837 19.95 116,471
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of HAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Haemonetics Corp (symbol HAE, CIK number 313143) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.